https://doi.org/10.5812/ijpr-157768

Erratum for Ruthenium (II) Complexes Based on Phenanthroline-Tetrazole as Possible Anticancer Agents [Iran J Pharm Res. 2023;22(1): e136738]

authors:

avatar Saeid Abaspour 1 , avatar Behzad Soltani 1 , * , avatar Hamed Hamishehkar 2 , avatar Moayad Hossaini Sadr 1

Chemistry Department, Faculty Science, Azarbaijan Shahid Madani University, Tabriz, Iran
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
IJ Pharmaceutical Research: Vol.23, issue 1; e157768
published online: November 26, 2024
article type: Correction
received: November 16, 2024
accepted: November 16, 2024
This corrects the article Ruthenium (II) Complexes Based on Phenanthroline-Tetrazole as Possible Anticancer Agents.

How To Cite Abaspour S, Soltani B, Hamishehkar H, Hossaini Sadr M. Erratum for Ruthenium (II) Complexes Based on Phenanthroline-Tetrazole as Possible Anticancer Agents [Iran J Pharm Res. 2023;22(1): e136738]. Iran J Pharm Res. 2024;23(1):e157768. https://doi.org/10.5812/ijpr-157768.

We would like to correct an error in the published article regarding the affiliation of the corresponding author (1). This mistake originated from the authors during the manuscript submission process. The correct affiliation of the corresponding author is as follows:

Chemistry Department, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran.

We sincerely apologize for this oversight and any confusion it may have caused. We take full responsibility for the error and appreciate your understanding.

Sincerely Yours,

Dr. Elham Rezaee

School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Editor-in-Chief of IJ Pharmaceutical Research

References

  • 1.

    Abaspour S, Soltani B, Hamishehkar H, Hossaini Sadr M. Ruthenium (II) Complexes Based on Phenanthroline-Tetrazole as Possible Anticancer Agents. Iran J Pharm Res. 2023;22(1). https://doi.org/10.5812/ijpr-136738.